Product Details
| Product Name:
WWL229 |
CAS No.:
1338575-28-2 |
| Purity:
98.15% |
Supply Ability:
10g |
| Release date:
2026/04/21 |
Product Introduction
Bioactivity
| Name | WWL229 |
| Description | WWL229 is a selective inhibitor of Ces3, acting by inhibiting recombinant Ces3 while not affecting Ces1f, ABHD6, or other tested serine hydrolases, and replicating the effects of WWL113 in adipocytes. |
| Storage | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year
Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 60 mg/mL (186.13 mM), Sonication is recommended.
10% DMSO+90% Saline : 2.5 mg/mL (7.76 mM), Sonication is recommended.
|
| Keywords | WWL-229 | WWL229 | WWL 229 | Inhibitor | inhibit | Ces3 |
| Inhibitors Related | MSU-42011 | Dehydrocholate sodium | Betulin | Ethyl phenylglyoxylate | Bakuchiol | Trans-2,3,4-Trimethoxycinnamic acid | HSL-IN-3 | Benzil | Nevadensin | Cetilistat | Lifibrol | Fenipentol |
| Related Compound Libraries | Bioactive Compound Library | Inhibitor Library | NO PAINS Compound Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
|
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |
United States